New T1D Family Event hosted by Tandem Diabetes Care, San Diego and the JDRF Southern California and Hawaii Chapter

October 19, 2021
5:30 pm (Pacific Time)

Learn about Tandem Diabetes Care and hear from featured speaker endurance athlete Sébastien Sasseville, who recently cycled across Canada to help promote JDRF Canada’s Access For All initiative. With the right mindset and the help of his t:slim X2™ insulin pump with Control-IQ® technology, Sébastien continues to redefine what is possible for someone living with type 1 diabetes.

More Info

Mind Over Miles – My Ride Across Canada

Join Tandem Diabetes Care, San Diego and the JDRF Southern California and Hawaii Chapter for a virtual event featuring endurance athlete Sebastien Sasseville, who recently cycled across Canada to help promote JDRF Canada’s Access For All initiative. With the right mindset and the help of his t:slim X2™ insulin pump with Control-IQ® technology, Sebastien continues to redefine what is possible for someone living with type 1 diabetes.  

Sebastien is an engaging motivational speaker who also ran across Canada, climbed Mt. Everest, and competed in the Sahara Ultra-Marathon in Egypt. He will be joined by his diabetes management coach, Cliff Scherb, the founder of Glucose Advisors and TriStarAthletes.com.  

The pair will discuss what they learned during Sebastien’s Ride Across Canada, along with useful takeaways for everyone — from the newly diagnosed to the endurance athlete.

Get to know Sebastien before the event by watching scenes from his Ride Across Canada.  

Responsible Use of Control-IQ Technology

Even with advanced systems such as the t:slim X2 insulin pump with Control-IQ technology, you are still responsible for actively managing your diabetes. Control-IQ technology does not prevent all high and low blood glucose events. The system is designed to help reduce glucose variability, but it requires your accurate input of information, such as meals and periods of sleep or exercise. Control-IQ technology will not function as intended unless you use all system components, including your CGM, infusion sets and pump cartridges, as instructed. Importantly, the system cannot adjust your insulin dosing if the pump is not receiving CGM readings. Since there are situations and emergencies that the system may not be capable of identifying or addressing, always pay attention to your symptoms and treat according to your healthcare provider’s recommendations

Important Safety Information:

RX ONLY.

Indications for Use:

t:slim X2 insulin pump

The t:slim X2 insulin pump with interoperable technology is an alternate controller enabled (ACE) pump that is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in individuals six years of age and greater. The pump is intended for single patient, home use and requires a prescription. The pump is indicated for use with NovoLog or Humalog U-100 insulin.

Control-IQ technology

Control-IQ technology is intended for use with a compatible integrated continuous glucose monitor (iCGM, sold separately) and ACE pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons six years of age and greater. Control-IQ technology is intended for single patient use. Control-IQ technology is indicated for use with NovoLog or Humalog U-100 insulin.

Contraindications and Warnings:

Control-IQ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ technology if using hydroxyurea.

Users of the t:slim X2 pump and Control-IQ technology must:

  • be able and willing to use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use;
  • test blood glucose levels as recommended by their healthcare provider;
  • demonstrate adequate carb-counting skills;
  • maintain sufficient diabetes self-care skills;
  • see healthcare provider(s) regularly; and
  • have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders;

The t:slim X2 pump, and the CGM transmitter and sensor must be removed before MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety information.

 

 

 

 

Event Contact

JDRF Southern California Chapter: San Diego
8582940743 | dkasper@jdrf.org

More from the Southern California Chapter

Chapter Homepage